NEXT Oncology /ID# 210717 — San Antonio, Texas

NEXT Oncology /ID# 210717 is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

NEXT Oncology /ID# 210717 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology /ID# 210717?

NEXT Oncology /ID# 210717 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology /ID# 210717 conducted?

NEXT Oncology /ID# 210717 has 1 clinical trials on record, with 1 currently active. Their work covers Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC).

Is NEXT Oncology /ID# 210717 accredited by Crixeo Health?

NEXT Oncology /ID# 210717 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology /ID# 210717?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.